Evidence map›Paper›PMID 32266216›Full record

ArticleFrontiers in chemistry2020

Geranylated Coumarins From Thai Medicinal Plant

Toshio Morikawa, Fenglin Luo, Yoshiaki Manse, Hidemi Sugita, Shunsuke Saeki, Saowanee Chaipech, Yutana Pongpiriyadacha, Osamu Muraoka, Kiyofumi Ninomiya

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Acta medica Philippina · 2024
    Article
  2. International journal of molecular sciences · 2023
    Article
  3. Anti-Alopecia Activity of Coumarin Derivatives Isolated fromPharmaceuticals (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Toshio MorikawaPharmaceutical Research and Technology Institute, Kindai University, Osaka, Japan.
Fenglin LuoPharmaceutical Research and Technology Institute, Kindai University, Osaka, Japan.
Yoshiaki MansePharmaceutical Research and Technology Institute, Kindai University, Osaka, Japan.
Hidemi SugitaPharmaceutical Research and Technology Institute, Kindai University, Osaka, Japan.
Shunsuke SaekiPharmaceutical Research and Technology Institute, Kindai University, Osaka, Japan.
Saowanee ChaipechPharmaceutical Research and Technology Institute, Kindai University, Osaka, Japan.
Yutana PongpiriyadachaFaculty of Science and Technology, Rajamangala University of Technology Srivijaya, Nakhon Si Thammarat, Thailand.
Osamu MuraokaPharmaceutical Research and Technology Institute, Kindai University, Osaka, Japan.
Kiyofumi NinomiyaPharmaceutical Research and Technology Institute, Kindai University, Osaka, Japan.
Kindai University · JPRajamangala University of Technology Srivijaya · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Geranylated coumarin constituents, kayeassamin I (

Indexed as

5α-reductase inhibitorcalophyllaceaegeranylated coumarinMammea siamensismammeasin

Identifiers

PMID32266216
PMCPMC7099204
OpenAlexW3012408205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.